ABSTRACT
Introduction
The impact of autonomic neuropathy on the cardiovascular system in diabetics is of utmost importance to exercise capacity and safety. Cardiovascular autonomic neuropathy (CAN) is manifested by abnormal heart rate, blood pressure, and redistribution of blood flow. The cardiovascular anomalies of autonomic neuropathy involve both the sympathetic and parasympathetic nervous systems (4) . Resting heart rate is primarily controlled by the parasympathetic system, whereas maximal heart rate and blood pressure responses to standing, sustained hand grip, and other types ofexercise are mainly functions of sympathetic activity (which controls blood vessel tone).
Prevalence of CAN, based on assesment of abnormal cardiovascular autonomic function tests, has been reported to be in the range of 90% (9, 10, 7) . One of the earliest manifestations of diabetic autonomic dysfunction is denervation of the cardiovascular system. The presence of abnormal cardiovascular function tests suggests poor prognosis of the disease (increased incidence of silent myocardial infarction, cardiac arrest, sudden cardiac death).
Reduced heart ate variability is the earliest indicator of CAN (i. e., abnormalities of heart rate control and vascular dynamics). Three major syndromes (cardiac denervation, exercise intolerance, and orthostatic hypotension) are associated with dysfunction of the cardiovascular autonomic nervous system (8) .
The present study examined the incidence of cardiac autonomic neuropathy (CAN) in type 2 diabetics and its correlation with retinopathy.
Materials and Methods
42 type 2 diabetics were included in the study per criteria recommended by WHO. Exclusion criteria included presence of hypertension, ischaemic heart disease, valvular heart disease, hepatic cirrhosis, other heart failure, fever.
Mercury sphygmomanometer, ECG machine and modified mouth piece were used for evaluation of cardiac reflexes.
We used the following cardiovascular tests: A/ Tests reflecting cardiac parasympathetic damage: 1/ Heart rate response to Valsalva manoeuvre.
The test was performed by the patient blowing into a mouth piece connected to a sphygmomanometer and holding it at a pressure of 40 mm Hg for 15 seconds while a continuous ECG was recorded.The manoeuvre was performed 3 times with interval of one minute in between. The result was expressed as the Valsalva ratio which is the ratio of the longest R-R interval after the manoeuvre to the shortest R-R interval during the manoeuvre. The mean of three Valsalva ratio was taken as the final value (normal Valsalva ratio>1.21, borderline between 1.11 and 1.20, abnormal<1.10).
2/ Heart rate variation during deep breathing
The patient sat quietly and breathed deeply at 6 breaths a minute (5 seconds in and 5 seconds out) for one minute. An ECG was recorded throughout the period of deep breathing with a marker used to indicate the onset of each inspiration and expiration. The maximum and minimum R-R intervals during each breathing cycle were measured and converted into beats/minute. The result was then expressed as the mean of the difference between maximum and minimum heart rates for the 6 measured cycles in beats/minute (normal response > 15 beats/minute, borderline 11-14 beats/minute, abnormal response < 10 beats/minute).
3/ Immediate heart rate response to standing
The test was performed with the patient lying quietly on a couch while heart rate was recorded continuously on ECG machine. The patient was asked to stand up unaided and the point at starting to stand was marked on ECG. The shortest R-R interval at or around the 15 th beat and largest R-R interval at or around the 30 th beat after starting to stand were measured with a ruler. The characteristic heart rate response was expressed by 30:15 ratio, which is normal if > 1.04, borderline between 1.01 and 1.03 and abnormal if < 1.00. B/ Tests reflecting sympathetic damage: 1/ Blood pressure (BP) to standing
The test was performed by measuring the patient,s BP while he was lying down quietly and again when he stood up. The postural fall in BP was taken as the difference between systolic BP lying and the systolic BP standing (normal response < 10 mm Hg, borderline 11-29 mm Hg, abnormal response > 30 mm Hg).
All borderline tests were interpreted as normal in this study. Heart rate variability with deep breathing was found abnormal in 14 patients (33.3%), normal in 19 cases (45.2%) and borderline in 9 diabetics (21.4%).
Results and Discussion
Valsalva ratio was abnormal in 12 patients (28.6%), normal in 10 cases 923.8%) and borderline in 20 cases (47.6%).
Decreased (abnormal) heart rate response to standing (30:15 ratio) was seen in 13 patients (31%), normal in 25 cases (59.5%) and borderline in 4 cases (9.5%) ( Table 3) . Majority (15) of patients (35.7%) with CAN had 2 abnormal cardiovascular reflexes ( Table 4) . 4 (9.5%) of patients had one abnormal cardiovascular reflex and the remaining 6 (14.3%)-3 or more abnormal CAN was observed in 25 (59.5%) cases. Parasympathetic neuropathy in 34 (81%) cases and sympathetic dysfunction in 13 (31%) of type 2 diabetics. It is in confirmity with the results of Ewing et al. (3) and Kahn et al. (5) . Heart rate response to deep breathing was the most sensitive test (positive in 33.3% followed by heart rate response to standing (31%).
Dizziness on standing was the most common symptom of CAN (42.9% of type 2 diabetics). Abnormal sweating was seen in 19% of patients, bladder symptoms-in 14.3% of cases, impotence-in 16.7%, diarrhoea-in 4.8%, and dysphagia-in 2.4% of type 2 diabetics.
25 patients with type 2 diabetes were with CAN. 15 (35.7%) of them had 2 abnormal cardiovascular reflex tests, 6 (14.3%) of patients had 3 or more abnormal CV reflexes and 4 (9.5%)-1 abnormal CV reflex.
Diabetic proliferative retinopathy was detected in 10 (23.8%) of type 2 diabetics. All of them had cardiac autonomic neuropathy.
Evaluation of cardiovascular reflexes in type 2 diabetics is an important, easy feasible and reproducible clinical method and is well correlated with diabetic proliferative retinopathy.
Patients with CAN have higher resting heart rates and lower maximal heart rates during exercise than diabetic patients without autonomic neuropathy (5). Unexplained sudden death not associated with myocardial infarction, in which the heart becomes unresponsive to nerve impulses (cardiac denervation syndrome), has been reported in diabetic patients with CAN (6, 3) . A variety of potential mechanisms have been proposed to explain sudden death, but an exact understanding of this occurrence remains speculative. Three of the most widely used tests for the determination of CAN include RRvariation during deep breathing, the Valsalva maneuver, and blood pressure response to standing (1) . According to the American Academy of Neurology, these are established tests, meaning that they are "accepted as appropriate by the practicing medical community for the given indication in the specified patient population" (2) .
Three major reasons explain the wide estimates of prevalence rates: 1/ different patient cohorts (e. g., type 1 or type 2 diabetes; clinic-or population-based), 2/ different assessment modalities with varied sensitivity and specificity (e.g., clinical or subclinical measures), and 3/ different minimal criteria used to define the presence of neuropathy.
